Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...

The bankrupt drugmaker and OxyContin manufacturer will be dissolved and its assets transferred to a new company.

Purdue Pharma has submitted a revised Chapter 11 bankruptcy plan proposing more than $7.4 billion in cash payments to ...

Purdue Pharma files a new $7.4B settlement plan with a U.S. bankruptcy court.in the U.S. to resolve opioid-related claims.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of ...

Purdue Pharma has filed a revised bankruptcy plan to finalize a $7.4 billion opioid settlement after the U.S. Supreme Court blocked its previous deal. The plan seeks to resolve lawsuits accusing the ...

Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying more than their previously ...

The plan is designed to resolve thousands of lawsuits that allege Purdue Pharma’s OxyContin played a significant role in the nationwide opioid addiction crisis. This move comes as part of a broader ...